711 participants
Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-08-27
- Start Date:
- 2021-06-30
- Completion:
- 2024-03-27
Conditions
- Heart Failure With Preserved Ejection Fraction
Interventions
- DRUG
- OTHER